Scarica l'app Stockscreener
3.03
3.50%
-0.11
Precedente Chiudi:
$3.14
Aprire:
$3.14
Volume 24 ore:
102.55K
Relative Volume:
0.30
Capitalizzazione di mercato:
$240.06M
Reddito:
$351.37M
Utile/perdita netta:
$-174.01M
Rapporto P/E:
-1.4638
EPS:
-2.07
Flusso di cassa netto:
$-126.94M
1 W Prestazione:
+4.12%
1M Prestazione:
-3.50%
6M Prestazione:
+11.81%
1 anno Prestazione:
-12.93%
Intervallo 1D:
$3.005
$3.1458
Intervallo di 1 settimana:
$2.895
$3.1684
Portata 52W:
$2.455
$4.02
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
Nome
Atea Pharmaceuticals Inc
Settore
Industria
Telefono
857-204-8109
Indirizzo
225 FRANKLIN STREET, BOSTON
Confronta AVIR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
3.025 | 249.18M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.18 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.45 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.96 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
808.25 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
330.21 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-13 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2023-08-10 | Downgrade | JP Morgan | Neutral → Underweight |
| 2022-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-18 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-10-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-25 | Iniziato | Evercore ISI | Outperform |
| 2020-11-24 | Iniziato | JP Morgan | Overweight |
| 2020-11-24 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Atea Pharmaceuticals Inc Borsa (AVIR) Ultime notizie
What MACD signals say about Atea Pharmaceuticals Inc.2025 Price Action Summary & Detailed Earnings Play Alerts - newser.com
Atea Pharmaceuticals Inc. stock trend outlook and recovery pathRisk Management & Technical Confirmation Alerts - newser.com
How hedge fund analytics apply to Atea Pharmaceuticals Inc. stock - newser.com
Will Atea Pharmaceuticals Inc. stock go up soonJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - newser.com
How to recover losses in Atea Pharmaceuticals Inc. stockWeekly Gains Report & Weekly Watchlist for Hot Stocks - newser.com
Analyzing recovery setups for Atea Pharmaceuticals Inc. investorsJuly 2025 Short Interest & AI Powered Market Entry Ideas - newser.com
What’s the recovery path for long term holders of Atea Pharmaceuticals Inc.Weekly Stock Recap & Real-Time Market Sentiment Alerts - newser.com
Weiss Ratings Reiterates "Sell (D-)" Rating for Atea Pharmaceuticals (NASDAQ:AVIR) - MarketBeat
What analysts say about Atea Pharmaceuticals Inc stockBearish Engulfing Patterns & Market-Leading Growth Rates - earlytimes.in
Atea Pharmaceuticals to Present New Data Supporting Combination of Bemnifosbuvir and Ruzasvir as Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025 - GlobeNewswire
Why Atea Pharmaceuticals Inc. stock is a must watch in 2025July 2025 Snapshot & Daily Profit Focused Screening - newser.com
Market reaction to Atea Pharmaceuticals Inc.’s recent news2025 Historical Comparison & Precise Swing Trade Entry Alerts - newser.com
Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing - Bain Capital
Relative strength of Atea Pharmaceuticals Inc. in sector analysisEarnings Overview Summary & Free High Accuracy Swing Entry Alerts - newser.com
Does Atea Pharmaceuticals Inc. show high probability of rebound2025 Top Gainers & Smart Allocation Stock Tips - newser.com
Using portfolio simulators with Atea Pharmaceuticals Inc. includedLayoff News & Accurate Buy Signal Notifications - newser.com
Historical volatility pattern of Atea Pharmaceuticals Inc. visualizedPortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com
What machine learning models say about Atea Pharmaceuticals Inc.Weekly Gains Summary & Community Verified Swing Trade Signals - newser.com
How to manage a losing position in Atea Pharmaceuticals Inc.July 2025 Trends & Weekly Return Optimization Alerts - newser.com
Voya Investment Management LLC Reduces Stock Position in Atea Pharmaceuticals, Inc. $AVIR - Defense World
What drives Atea Pharmaceuticals Inc stock priceInstitutional Buying Trends & Machine Learning Stock Picks, Daily - earlytimes.in
Atea Pharmaceuticals Inc Azioni (AVIR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Atea Pharmaceuticals Inc Azioni (AVIR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
506,497 |
| Duncan Barbara Gayle | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Polsky Bruce | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
95,206 |
| Adams Jerome M. | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Lucidi Bruno | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
112,750 |
| BERGER FRANKLIN M | Director |
Dec 10 '24 |
Sale |
2.85 |
359,606 |
1,023,475 |
451,897 |
0.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):